Literature DB >> 7769425

Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG.

T Nakata1, K Shimamoto, S Yonekura, N Kobayashi, T Sugiyama, K Imai, O Iimura.   

Abstract

In familial amyloidotic polyneuropathy (FAP), the peripheral nervous system is predominantly impaired. Cardiac sympathetic function has not been directly assessed. A 65-yr-old man with severe peripheral neuropathy due to primary systemic amyloidosis was studied. Echocardiograms and scintigraphic examinations with 20Tl and 99mTc-pyrophosphate demonstrated highly thickened but normally perfused left ventricular walls with intense diffuse amyloid deposits. No definite myocardial activity of [123I]metaiodobenzylguanidine (MIBG) was detected in any cardiac region, indicating lack of sympathetic nerve endings. Despite maintained cardiac contractility, left ventricular diastolic performance and heart rate variability assessed by power spectral analysis were markedly depressed. Thus, the myocardial defect of MIBG activity may provide direct evidence of impaired cardiac sympathetic nerve endings due to amyloid deposits in FAP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769425

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

1.  Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.

Authors:  David S Goldstein; Courtney Holmes; Patti Sullivan; Deborah C Mash; Ellen Sidransky; Alessandro Stefani; Irwin J Kopin; Yehonatan Sharabi
Journal:  Parkinsonism Relat Disord       Date:  2015-07-17       Impact factor: 4.891

2.  Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts.

Authors:  T Nakata; K Miyamoto; A Doi; H Sasao; T Wakabayashi; H Kobayashi; K Tsuchihashi; K Shimamoto
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

3.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

Review 4.  Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Sabahat Bokhari; Thibaud Damy; Sharmila Dorbala; Brian M Drachman; Marianna Fontana; Martha Grogan; Arnt V Kristen; Isabelle Lousada; Jose Nativi-Nicolau; Candida Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Ronald Witteles; Giampaolo Merlini
Journal:  Circ Heart Fail       Date:  2019-09-04       Impact factor: 8.790

Review 5.  Molecular imaging of amyloidosis: will the heart be the next target after the brain?

Authors:  Wengen Chen; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 6.  Recent advances in the noninvasive strategies of cardiac amyloidosis.

Authors:  Lei Zhao; Quan Fang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 7.  Nuclear imaging for cardiac amyloidosis.

Authors:  Walter Noordzij; Andor W J M Glaudemans; Simone Longhi; Riemer H J A Slart; Massimiliano Lorenzini; Bouke P C Hazenberg; Claudio Rapezzi
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

Review 8.  Use of Noninvasive Imaging in Cardiac Amyloidosis.

Authors:  Raymundo Alain Quintana-Quezada; Syed Wamique Yusuf; Jose Banchs
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-07

Review 9.  Nuclear imaging modalities for cardiac amyloidosis.

Authors:  Sabahat Bokhari; Reehan Shahzad; Adam Castaño; Mathew S Maurer
Journal:  J Nucl Cardiol       Date:  2014-02       Impact factor: 5.952

Review 10.  Nuclear imaging in cardiac amyloidosis.

Authors:  A W J M Glaudemans; R H J A Slart; C J Zeebregts; N C Veltman; R A Tio; B P C Hazenberg; R A J O Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-21       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.